9780763777098

HIV Essentials

by
  • ISBN13:

    9780763777098

  • ISBN10:

    0763777099

  • Edition: 3rd
  • Format: Paperback
  • Copyright: 2009-09-25
  • Publisher: Jones & Bartlett Learning
  • Purchase Benefits
  • Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $24.95

Summary

The World's Leading Experts Provide all the 'Essentials' Needed to Manage Patients in the Office, on the Ward, and in the Intensive Care Unit!HIV Essentials 2010 incorporates the latest clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management and prevention of HIV infection and its complications.

Table of Contents

Overview Of HIV Infectionp. 1
Overviewp. 2
Stages of HIV Infectionp. 3
Acute HIV Infectionp. 4
Differential Diagnosisp. 4
Signs and Symptomsp. 4
Laboratory Findingsp. 4
Diagnostic Testingp. 5
Managementp. 5
Diagnosis and Evaluation of HIV Infectionp. 6
HIV Antibody Testingp. 7
ELSAp. 7
Western Slotp. 7
Othersp. 7
HIV Viral Load Assaysp. 9
Usesp. 9
Assays and Interpretationp. 9
Indicationsp. 11
Initial Assessment of HIV-infected Patientsp. 11
Clinical Evaluationp. 11
Laboratory Testingp. 12
CD4 Cell Countp. 14
Treatment Of HIV Infectionp. 15
Initiation of Antiretroviral Therapyp. 16
Selection of an Optimal Initial
Antitetroviral Regimenp. 21
Complications of HIV Therapyp. 26
Lipodystrophy Syndromep. 26
Antiretroviral Therapy Adverse Effectsp. 29
Bleeding Eventsp. 30
Bone Marrow Suppressionp. 30
Cardiovascularp. 32
Central Nervous Systemp. 33
Gastrointestinal Intolerancep. 34
Hepatic Failurep. 35
Hepatoxicityp. 37
Hyperlipidemiap. 39
Hypersensitivity Reactionp. 41
Insulin Resistance/Diabetes Mellitusp. 43
Lactic Acidosis/Hepatic Steatosisp. 44
Lipodystrophyp. 47
Nephrolithiasis/Urolithiasis/Crystallunap. 48
Nephrotoxicityp. 49
Neuromuscular Weakness Syndromep. 51
Osteonecrosisp. 52
Osteopeniap. 53
Peripheral Neuropathyp. 54
Stevens-Johnson Syndromep. 55
References and Suggested Readingsp. 58
Treatment Failure and Resistance Testingp. 60
Antiretroviral Treatment Failurep. 61
Virologic Failurep. 61
Immunologic Failurep. 62
Clinical Failurep. 62
Usual Sequence of Treatment Failurep. 62
Principles of Resistance Testingp. 66
Types of Resistance Testingp. 67
Genotype Testingp. 68
Phenotype Testingp. 68
Other Options for Resistance Testingp. 69
Co-Receptor Tropism Assayp. 69
Indications for and Approach to Resistance Testingp. 69
Important Genotype-Resistant Patternsp. 71
Nucleoside Reverse Transcriptase inhibitors (NRTI's)p. 71
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI's)p. 73
Protease Inhibitors (PI's)p. 74
Prophylaxis And Treatment of Opportunistic Infectionsp. 76
Prophylaxis of Opportunistic Infectionsp. 77
Treatment of Opportunistic Infectionsp. 84
Aspergillosis, Invasivep. 85
Bacterial Respiratory Diseasesp. 86
Bartonella Infectionsp. 83
Campylobacteriosisp. 89
Candidiasis (Mucosal)p. 89
Chagas Diseasep. 92
Clostridium difficile Diarrhea/Colitisp. 92
Coccidioidomycosisp. 93
Cryptococcal Meningitisp. 94
Cryptosporidiosisp. 96
Cytomegalovirus (CMV) Diseasep. 97
Hepatitis B Virus (HBV)p. 100
Hepatitis C Virus (HCV)p. 102
Herpes Simplex Virus (HSV) Diseasep. 107
HHV-6 Infectionp. 108
HHVS Infectionp. 109
Histoplasma capsulatump. 109
Human Papillomavirus (HPV) Diseasep. 111
Isospora belli Infectionp. 112
Leishmaniasis, Cutaneousp. 113
Leishmaniasis, Visceralp. 113
Malariap. 114
Malaria, Severep. 114
Malaria, Uncomplicatedp. 115
Microsporidiosisp. 115
Mycabaterium avium Complex (MAC) diseasep. 117
Mycobaterium Tuberculosisp. 118
Penicilliosisp. 120
Pneumocystis Pneumonia (PCP)p. 121
Progressive Multifocal Leukoencephalopathy (PML)p. 123
Salmonellosisp. 124
Shigellosisp. 125
Toxoplasma gondii Encephalitisp. 126
Treponema pallidum (Syphilis)p. 127
Varicella-Zoster Virus (VZV) Diseasep. 130
Complications of HIV infectionp. 132
Hematologic Complicationsp. 133
Thrombocytopeniap. 133
Anemiap. 133
Neutropeniap. 134
Eosinophiliap. 355
Oncologic Complicationsp. 135
Kaposi's Sarcomap. 135
Non Hodgkin's Lymphomap. 136
Primary CNS Lymphomap. 136
Cervical Cancerp. 137
Anal Cancerp. 137
Endocrine Complicationsp. 137
Adrenal Insufficiencyp. 137
Hypogonadismp. 138
Thyroid Diseasep. 138
Pancreatitisp. 139
Hyperglycemiap. 139
Hypoglycemiap. 139
Ovarian Complicationsp. 140
Bone Diseasep. 140
Gastrointestinal Complicationsp. 141
Anorexiap. 141
Nausea/Vomitingp. 141
Diarrheap. 142
Oral or Esophageal Ulcersp. 142
HIV Chofangiopathyp. 143
Renal Complicationsp. 143
HIV-Associated Nephropathyp. 143
Medication-Related Renal Diseasep. 144
HCV-Associated Renal Diseasep. 145
Heroin Nephropathyp. 145
Cardiac Complicationsp. 145
HIV-Related Cardiomyopathyp. 145
Pericarditis/Pericardial Effusionp. 146
Tricuspid Valve Endocarditisp. 146
Pulmonary Complicationsp. 147
Pulmonary Hypertensionp. 147
Lymphocytic Interstitial Pneumonitisp. 147
Emphysemap. 147
Pulmonary Kaposi's Sarcomap. 148
HEENT Complicationsp. 148
Aphthous Ulcersp. 148
Oral Hairy Leukoplakiap. 148
Salivary Gland Enlargementp. 148
Lymphoepithelial Cystsp. 148
Gingivitis/Periodontitisp. 149
Musculoskeletal Complicationsp. 149
HIV Arthropathyp. 149
Reiter's Syndromep. 149
Pyomyositisp. 149
HIV/NRTI-Related Myopathyp. 150
Rhabdomyolysisp. 150
Neurologic Complicationsp. 150
Distal Sensory Neuropathyp. 150
Other forms of Neuropathyp. 151
HIV-Assodated/AlDS Dementiap. 151
Psychiatric Complicationsp. 152
Depressionp. 152
Maniap. 152
Insomniap. 152
Dermatologic Complicationsp. 153
Herpes Simplex Infectionp. 153
Varicella-Zosier Infectionp. 154
Molluicum Contagiosump. 154
Oral Hairy Leukoplakiap. 154
Wartsp. 154
Staphylococcal Infectionsp. 155
Bacillary Angiomatosisp. 155
Fungal Infectionsp. 156
Seborrheic Dermatitisp. 156
Psoriasisp. 156
Eosinophilic Folliculitisp. 157
Xerosis/Ichthyosisp. 157
HIV Infection and Pregnancyp. 158
Overviewp. 159
Initial Evaluationp. 159
Initiation of Antiretroviral Therapy in Pregnancyp. 159
Goals of Therapy and Monitoringp. 160
Management of HIV-infected Pregnant Women Currently Receiving Antiretroviral Therapyp. 161
Other Management and Monitoring Considerationsp. 162
Postpartum Managementp. 163
Post-Exposure Prophylaxisp. 170
Occupational post-Exposure Prophylaxisp. 171
Nonoccupational Post-Exposure Prophylaxisp. 177
Evaluationp. 177
Use of Antiretroviral Therapyp. 177
Follow-Up Testingp. 178
Antiretroviral Drug Summariesp. 180
p. 225
IAS-USA Drug Resistance Mutations in HIVp. 226
User Notesp. 232
References to the User Notesp. 236
p. 239
Selected Key Internet Resourcesp. 240
Indexp. 241
Table of Contents provided by Ingram. All Rights Reserved.

Rewards Program

Write a Review